期刊
FRONTIERS IN CHEMISTRY
卷 6, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2018.00422
关键词
coral-associated fungus; Aspergillus terreus; butenolide derivatives; structure reassignments; alpha-glucosidase inhibitors
资金
- National Science Fund for Distinguished Young Scholars [81725021]
- Innovative Research Groups of the National Natural Science Foundation of China [81721005]
- Program for Changjiang Scholars of Ministry of Education of the People's Republic of China [T2016088]
- National Natural Science Foundation of China [21702067, 81573316, 81703580, 81502943]
- China Postdoctoral Science Foundation [2017M610479, 2018T110777]
- Academic Frontier Youth Team of HUST
- Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College (HUST)
Nine novel butenolide derivatives, including four pairs of enantiomers, named (+/-)-asperteretones A-D (1a/1b-4a/4b), and a racemate, named asperteretone E (5), were isolated and identified from the coral-associated fungus Aspergillus terreus. All the structures were established based on extensive spectroscopic analyses, including HRESIMS and NMR data. The chiral chromatography analyses allowed the separation of (+/-)-asperteretones A-D, whose absolute configurations were further confirmed by experimental and calculated electronic circular dichroism (ECD) analysis. Structurally, compounds 2-5 represented the first examples of prenylated gamma-butenolides bearing 2-phenyl-3-benzyl-4H-furan-1-one motifs, and their crucial biogenetically related metabolite, compound 1, was uniquely defined by an unexpected cleavage of oxygen bridge between C-1 and C-4. Importantly, (+/-)-asperteretal D and (4S)-4-decarboxylflavipesolide C were revised to (+/-)-asperteretones B (2a/2b) and D (4), respectively. Additionally, compounds 1a/1b-4a/4b and 5 were evaluated for the alpha-glucosidase inhibitory activity, and all these compounds exhibited potent inhibitory potency against alpha-glucosidase, with IC50 values ranging from 15.7 +/- 1.1 to 53.1 +/- 1.4 mu M, which was much lower than that of the positive control acarbose (IC50 = 154.7 +/- 8.1 mu M), endowing them as promising leading molecules for the discovery of new a-glucosidase inhibitors for type-2 diabetes mellitus treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据